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Investigation of the effects of serotonin on memory formation in the chick revealed an
action on at least two 5-HT receptors. Serotonin injected intracerebrally produced a biphasic
effect on memory consolidation with enhancement at low doses and inhibition at higher
doses.The non-selective 5-HT receptor antagonist methiothepin and the selective 5-HT2B/C
receptor antagonist SB221284 both inhibited memory, suggesting actions of serotonin on
at least two different receptor subtypes.The 5-HT2B/C and astrocyte-speciﬁc 5-HT receptor
agonist, ﬂuoxetine and paroxetine, enhanced memory and the effect was attributed to
glycogenolysis. Inhibition of glycogenolysis with a low dose of DAB (1,4-dideoxy-1,4-
imino-D-arabinitol) prevented both serotonin and ﬂuoxetine from enhancingmemory during
short-term memory but not during intermediate memory. The role of serotonin on the 5-
HT2B/C receptor appears to involve glycogen breakdown in astrocytes during short-term
memory, whereas other published evidence attributes the second period of glycogenolysis
to noradrenaline.
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INTRODUCTION
The importance of glycogenolysis for successful learning has been
overwhelmingly demonstrated (O’Dowd et al., 1994; Hertz et al.,
2003, 2013; Gibbs et al., 2006a, 2007; Suzuki et al., 2011; Gold
and Korol, 2012; Duran et al., 2013). During one-trial aversive
learning in the day-old chick, the exact timing of not one, but
three periods of glycogenolysis is well established, i.e., 5, 30,
and 55 min post-training (Hertz and Gibbs, 2009). Our previous
experiments focused on the glycogenolytic and glycogen synthesis-
promoting effect of noradrenaline, via β2- and α2-adrenergic
receptors respectively (Gibbs et al., 2008a; Gibbs and Hutchin-
son, 2012). It indicated β2-adrenergic receptor stimulation as the
signal leading to the second glycogenolytic period, but also that
noradrenalinewas not implicated in starting the ﬁrst. Several other
transmitters, including serotonin, activate glycogenolysis in brain
tissue and in cultured astrocytes (Quach et al., 1982; Cambray-
Deakin et al., 1988; Magistretti, 1988; Chen et al., 1995; Kong
et al., 2002; Darvesh and Gudelsky, 2003). This study investi-
gates serotonin in detail, and it eventually focuses on the role of
the 5-HT2B receptor. However, unlike noradrenaline, which also
stimulates glycogen synthesis (Hertz et al., 2007; Hutchinson et al.,
2008, 2011; Gibbs and Hutchinson, 2012), 5-HT is not known to
stimulate glycogen synthesis in brain.
As in our previous studies, this report uses avoidance training in
the day-old chick, a precocious animal. Before or during the train-
ing drugs are injected into the intermediate medial mesopallium
(IMM), an avian equivalent of the mammalian cerebral cortex.
This learning task in the premature chick brain shares many
characteristics with inhibitory learning in the adult mammalian
hippocampus (Izquierdo and Medina, 1997). During a 10 s learn-
ing period the chicks learn to associate a red bead with aversive
taste, and consolidation of this memory is indicated by unwill-
ingness to peck at untainted red beads, while freely pecking at
corresponding blue beads. Timeof injection-dependent inhibition
of learning by metabolic inhibitors and restoration of memory by
speciﬁc substrates at precisely determined times allow determina-
tion of speciﬁc metabolic events and their neuronal or astrocytic
localization (Gibbs et al., 2008a).
Following inhibition of glycogenolysis during either of the two
ﬁrst glycogenolytic periods, memory disappears after 30 min and
inhibition of the third glycogenolytic period leads to amnesia
after 70 min. The ﬁrst period of glycogenolysis almost imme-
diately after training, provides the substrate for formation of
transmitter glutamate (Hertz et al., 2003; Gibbs et al., 2007), an
astrocytic process (Hertz, 2011). The transmitter stimulating
glycogenolysis at this time cannot be noradrenaline, since an
antagonist of the β2-adrenergic drug, propranolol, administered
prior to the ﬁrst period of glycogenolysis does not inhibit mem-
ory (Gibbs and Summers, 2002). The next glycogenolytic period
around 30min is triggered by noradrenaline (Gibbs and Summers,
2002). Like the ﬁrst glycogenolytic period it also occurs immedi-
ately before a known release of transmitter glutamate (Daisley
et al., 1998). It is likely, although not proven that glycogen again
serves as a glutamate precursor. However, unlike the ﬁrst period
the use of glycogen is not reﬂected by a signiﬁcant decrease in
its level (O’Dowd et al., 1994), probably reﬂecting that nora-
drenaline stimulates both glycogenolysis and glycogen synthesis.
The fate of pyruvate/lactate derived fromglycogen during the third
glycogenolytic period 55 min post-training is unknown, and inhi-
bition of glycogenolysis causes memory to disappear around the
onset of long-term protein-synthesis-dependent memory (Gibbs
and Ng, 1984). In contrast to the ﬁrst two glycogenolytic periods
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intracerebral injection of the glutamate precursor glutamine does
not rescue memory after the third glycogenolytic period (Gibbs
et al., 2008a).
Our previous studies have suggested that serotonin has both
memory-enhancing and memory-inhibitory effects on learning
in day-old chicks (Gibbs et al., 1987; Hertz and Gibbs, 2009). The
prime purpose of the present study has been to determine which
5-HT receptor is responsible for the memory-enhancing effect of
serotonin and to investigate whether itmay play an essential role in
triggering the ﬁrst glycogenolytic response during learning in day-
old chicks. During the course of this investigation informationwas
also gathered regarding the ability of high concentrations of sero-
tonin to inhibit memory. In this study serotonin itself, different
serotonin antagonists, and the subtype-speciﬁc 5-HT2B receptor
agonists, ﬂuoxetine, and paroxetine were used.
There are seven 5-HT receptor families: 5-HT1 – 5-HT7
(Uphouse, 1997). With the exception of the 5-HT3 receptor, a
ligand-gated cation channel, they are all G protein-coupled. 5-
HT1 (Uphouse, 1997) and 5-HT5 (Volk et al., 2010) receptors are
Gi/Go-coupled and their activation decreases adenylate cyclase
activity. However, blockade of presynaptic 5-HT1 receptors also
enhances 5-HT2-mediated activities (Fox et al., 2010). Members
of the 5-HT2 family (A, B, and C) are Gq/G11-coupled and sig-
nal via phospholipase C (PLC) and the phosphatidylinositide
second messenger system. This includes a rise in free cytosolic
Ca2+ ([Ca2+]I which is of major importance because a [Ca2+]I
increase is indispensable for glycogenolysis, not only in muscle
(Ozawa, 1972, 2011) but also in brain (Ververken et al., 1982) and
in cultured astrocytes (Xu et al., 2014). 5-HT4, 5-HT6, and 5-HT7
receptors are Gs-coupled and linked to activation of the adeny-
late cyclase system, generating c-AMP (Uphouse, 1997). However,
in contrast to prevailing concepts, c-AMP on its own cannot elicit
glycogenolysis (Ozawa,1972,2011;Ververken et al., 1982),whereas
it can increase the glycogenolytic effect during increases in [Ca2+]i
(Ozawa, 1972).
The two “serotonin-speciﬁc reuptake inhibitors” (SSRIs), ﬂu-
oxetine, and paroxetine are speciﬁc 5-HT2B agonists in cultured
astrocytes (Li et al., 2008; Zhang et al., 2010; Hertz et al., 2012).
Diaz et al. (2012) have conﬁrmed that ﬂuoxetine administration
stimulates the 5-HT2B receptor, probably also on raphe neurons,
which were found to express 5-HT2B receptors. This might be the
reason for serotonin reuptake inhibition, which the authors still
regarded as the mechanism for the functional effects of SSRI’s.
However, this is impossible in the cultured astrocytes, which
express no serotonin transporter (SERT; Kong et al., 2002). Nev-
ertheless, in cultured cells both ﬂuoxetine and paroxetine are
subtype-speciﬁc agonists of the astrocytic, but not the neuronal,
5-HT2B receptor, with a moderately high, almost similar, acute
afﬁnity, i.e., a Ki value for displacement of serotonin of 70 nM
(Hertz et al., 2012). This is a pronounced difference from their
afﬁnity for all other 5-HT receptors, and since the 5-HT2B recep-
tor was unknown at the time ﬂuoxetine came on the market, the
conclusion that it had negligible receptor afﬁnity was correct at
that time. The almost similar afﬁnities of ﬂuoxetine and paroxe-
tine for the 5-HT2B receptor (Zhang et al., 2010) occur in spite of
the fact that the afﬁnities of these two drugs for the 5-HT trans-
porter (SERT) and for the 5-HT2C receptor are widely different
(Wong and Bymaster, 1995). These drugs are therefore able to dis-
tinguish between the two 5-HT2 receptor subtypes and between
effects on astrocytes andneurons. Provided they are approximately
equipotent, the possibility that they act by inhibiting the SERT is
eliminated.
Different 5-HT receptor families and their subtypes are more
or less selectively inhibited by a large variety of drugs. In the
present study we tested methiothepin, an inhibitor of 5-HT1,
5-HT2, 5-HT5, 5-HT6, and 5-HT7 receptors, although with dif-
ferent potencies (Misane and Ogren, 2000), and the more speciﬁc
5-HT2B/C receptor antagonist, SB221284 (Bromidge et al., 1998).
Two different learning paradigms were used: (i) strong learn-
ing established by pecking on a bead tainted with the taste aversant
anthranilate in undiluted form (100% anthranilate), a procedure
which leads to spontaneous consolidation into long-term mem-
ory; and (ii) weak learning after similar exposure but to 20%
anthranilate, which initially also leads to memory retention, but
where the memory trace normally fades after 30 min, but can be
rescued by speciﬁc interventions.
MATERIALS AND METHODS
ANIMALS
Between 120 and 180 day-old cockerels from an egg-laying hybrid
strain (New Hampshire, Rhode Island Red, White Leghorn and
Black Australorp) were delivered from a local hatchery (Wag-
ner’s Poultry, Coldstream,VIC, Australia) on the morning of each
experiment. Details of housing and experimental conditions are
described in detail by Gibbs and Summers (2002). Chicks were
divided into groups of 16–20.
DRUGS AND THEIR ADMINISTRATION
Drugs: (i) The universal 5-HT receptor agonist, 5-
hydroxytryptamine hydrochloride, acting potently at 5-HT2A and
5-HT2B receptors (Doyle et al., 1986; Misane and Ogren, 2000;
Li et al., 2010), as well as at 5-HT6 and 5-HT7 receptors but less
potently at 5-HT1 receptors (Granados-Soto et al., 2010); 5-HT3
(Chetty et al., 2006), 5-HT4 (Prins et al., 2000), 5-HT5 (Thomas
et al., 2000; Nelson, 2004), and 5-HT6 (Monsma et al., 1993)
receptors; (ii) ﬂuoxetine hydrochloride and paroxetine hydrochlo-
ride (from Sigma-Aldrich, St. Louis, MO, USA), subtype-speciﬁc,
almost equipotent agonists at the astrocytic 5-HT2B recep-
tor; (iii) methiothepin maleate (1-[10,11-dihydro-8-(methyl-
thio)dibenzo(Z)[b,f]thiepin-10-yl]-4-methylpiperazine maleate),
from Research Biochemicals, Inc, a non-speciﬁc antagonist of
all 5-HT receptors, except 5-HT3 and 5-HT4 (Misane and
Ogren, 2000), which has high afﬁnity for 5-HT2A (Briejer
et al., 1997) and 5-HT2B receptors (Glusa and Pertz, 2000),
5-HT5 receptors (Thomas et al., 2000), 5-HT6 receptors (Mis-
ane and Ogren, 2000) and 5-HT7 receptors (Jänichen et al.,
2005), but lower afﬁnity for at least some of the 5-HT1 recep-
tors (Misane and Ogren, 2000); (iv) the selective 5-HT2B/C
receptor antagonist SB221284 (2,3-dihydro-5-(methylthio)-N-3-
pyridinyl-6-(triﬂuoromethyl)-1H-indole-1-carboxamide), from
Tocris Cookson Ltd. UK.All drugs were prepared in sterile physio-
logical saline (154mMNaCl). Central injections of 5 or 10 μl were
made into the IMM of each hemisphere using a Hamilton Repeat-
ing Dispenser syringe ﬁtted with a 27-gage needle with a stop
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controlling the depth to 3.5 mm. Control chicks were injected
with saline; (v) the glycogenolysis inhibitor DAB (1,4-dideoxy-
1,4-imino-D-arabinitol; Sigma-Aldrich, St.Louis, MO, USA) was
administered by subcutaneous injections of 100 μl.
All experimental procedures were in accordance with the
guidelines approved by the Monash University Animal Ethics
Committee and comply with the 1997 Australian Code of Prac-
tice for the care and Use of Animals for Scientiﬁc Purposes. All
efforts were made to minimize both the suffering and the num-
ber of animals used. Chicks were killed at the completion of each
experiment by CO2 inhalation.
EXPERIMENTAL PROCEDURE
The procedures have been described in detail elsewhere (Gibbs
and Summers, 2002; Gibbs et al., 2008a). Chicks were familiarized
with the introduction of small shiny beads and subsequently, with
colored red and blue beads, into their cage prior to the training
trial. The beads were dipped in water. Chicks peck equally at both
colors of the bead. For the training trial, an identical red bead was
dipped in either 100% methyl anthranilate (strongly reinforced
training) or 20%anthranilate diluted in alcohol (weakly reinforced
training) and presented to each pair of chicks for 10 s. On the
retention test, the chicks were presented with a clean dry red bead,
followed by a clean dry blue bead 2.5 min later, and allowed 10 s
to peck at each bead. The number of pecks at each bead and the
latency to the ﬁrst peck in all trials with the colored beads was
recorded on a hand held logger, later decoded by computer. Drugs
were administered, and testing carried out, at predetermined times
relative to the learning trial. Memory is retained after both weakly
reinforced and strongly reinforced training, in the former for only
30 min (unless reinforced pharmacologically), compared to least
24 h after the latter (unless inhibited pharmacologically), although
with two brief declines in intensity, normally at 15 and 55 min.
Memory retention is indicated by many fewer pecks on the blue
bead compared to the red one.
At the completion of each experiment, data were retrieved from
the computer and results calculated. At this point the pecking data
from chicks failing to peck at the red bead during training or at
the blue bead on test were excluded from further analysis. Memory
was indexed by a discrimination ratio (DR), deﬁned as the ratio of
the number of pecks at the blue bead to the total number of pecks
at the red and the blue bead. All statistical tests were one-way
ANOVA unless otherwise speciﬁed. The one-way ANOVA were
followed by post hoc analysis using Dunnett’s test, with P set at
0.05.
EXPERIMENTAL PROTOCOLS
Dose-response relationships
Dose-response studies were performed with injection immedi-
ately after training and memory tested 120 min later to establish
enhancement of memory after weakly reinforced training (on
20% methyl anthranilate) or inhibition of memory after strongly
reinforced training (on 100% methyl anthranilate).
Time of injection
Injections of both agonists and antagonists were made at
times between 5 min before and 40 min after training to
determine the times at which memory consolidation could be
impaired or enhanced. Retention was tested 120 min after
training.
Time of test
With a time of injection determined, several groups of chicks
were injected with the agonist or antagonist and memory reten-
tion tested in separate groups of chicks at discrete time intervals
after training to identify the memory stage at which the drug effect
became apparent.
Speciﬁcity of drug/receptor interaction
To determine subtype-speciﬁcity of 5-HT’s memory-enhancing
effect after weakly reinforced learning, its ability to enhance
memory was tested in the presence of the more or less selec-
tive antagonists (SB2212384 or methiothepin). The antagonist
was administered systemically 5 min before the agonist was given
20 min after training. Subtype-speciﬁcity was indicated by the
requirement of a higher dose of the agonist to enhance memory
in the presence of the antagonist.
DAB challenges of memory enhancement of weak training by 5-HT
and ﬂuoxetine
To determine whether glycogenolysis was involved in the enhance-
ment of memory by 5-HT agonists, the inhibitor of glycogenolysis,
DAB,was injected subcutaneously 5min beforeweak trainingwith
the agonist given 2.5 min after training, or 15 min before agonist
injection at 20 min.
RESULTS
DOSE-RESPONSE FUNCTION FOR 5-HT WITH WEAKLY- AND
STRONGLY-REINFORCED TRAINING
Tenμl of ﬁve different concentrations of 5-HT from0.1 to 10 nmol
per hemisphere (nmol/hem)were injectedbilaterally into the IMM
within 10 s after training on 20%anthranilate (Figure 1A) or 100%
anthranilate (Figure 1B). Control chicks were injected with saline.
Retention was tested at 120 min after training.
After training with the low anthranilate concentration, the
saline control chicks showed very little retention of the aver-
sive nature of the red bead at 120 min, with almost the same
number of pecks on the red bead as on the blue bead, giving a
mean DR of 0.625. There was a signiﬁcant effect of serotonin
dose [F(5,101) = 2.68, P = 0.026] with retention levels in chicks
injected with 2.5 nmol/hem being signiﬁcantly greater than saline
(P < 0.05). Higher doses of serotonin did not promote consol-
idation. The maximum DR obtained did not quite reach that of
chicks trained on 100% anthranilate.
When administered after strongly reinforced training on 100%
anthranilate (Figure 1B) the higher doses of serotonin (5 and
10nmol/hem),whichdidnot enhancememory consolidationwith
weakly reinforced training, now inhibitedmemory [F(5,98) = 2.90,
P = 0.017; 2.5 and 5 nmol/hem, P < 0.05].
EFFECTIVE TIME OF ADMINISTRATION AND RETENTION FUNCTION
Weakly reinforced training
Separate groups of chicks trained with 20% anthranilate injected
with 2.5 nmol/hem serotonin or saline immediately after training
were tested at different intervals (Figure 2A). The saline injected
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FIGURE 1 | Dose-response relationship for serotonin injected
immediately after training. (A) After training on 20% anthranilate there was
signiﬁcant enhancement of consolidation with a dose of 2.5 nmol/hem.
(B) After strongly reinforced training on 100% anthranilate, doses of 5.0 and
10 nmol resulted in memory loss, n = 14–20 per group, *P < 0.05 compared
to saline.
FIGURE 2 |The effect of serotonin onmemory retention in chicks given
weakly reinforced training. (A) 2.5 nmol/hemdose of serotonin promoted the
consolidation ofmemorywhen injected between+0 and 25min after training
(ﬁlled squares),whereas saline did not [(open square) n = 14–20 per group]. (B)
When the samedose of serotoninwas injected immediately after training
memorywas intact or almost intact after 120min but the short-lasting amnestic
periods,which normally occur at 15 and 55minwere delayed (ﬁlled squares),
n = 14–20 per group, *P < 0.05 compared to saline-injected animals.
controls did not remember at 120 min, whereas memory was
intact in those treated with serotonin at any time during the ﬁrst
25 min [F(7,138) = 7.18, P < 0.001], but not thereafter. Sero-
tonin had a greater effect when injected 10 min after training and
this suggests that the dose-response relationship seen in Figure 1
could have been more pronounced had this time of injection been
used.
Normally, after training with 100% anthranilate and no drug-
treatment, chicks tested for retention at selected times between
5 and 120 min, show dips in discrimination memory at 15 and
at 55 min (Gibbs and Ng, 1979). At these two times the DRs
falls to ∼0.6. A quantitatively similar decline occurred when
weakly reinforced trainingwas followed by administration of sero-
tonin (at +0 min) but with the dips in retention being delayed
to 20–25 and 80 min, respectively (Figure 2B). This is similar
to what occurs with noradrenaline and other agents that facil-
itate weakly reinforced memory (Gibbs and Summers, 2002).
All DRs, apart from those tested at 20, 25, and 80 min, were
signiﬁcantly different from that after saline [F(14,251) = 4.752,
P < 0.001].
Strongly reinforced training
As seen in the dose-response data, inhibition of memory occurred
with higher doses of serotonin. Injection of 5 nmol/hem at
different times after strongly reinforced training, led to amne-
sia when injections were made between 5 min before and 2.5 min
after training (Figure 3A). One-way ANOVA revealed a signiﬁ-
cant effect of times of injection close to training [F(6,115) = 5.67,
P < 0.001] with −5, +0, and 2.5 min, being signiﬁcantly different
(P < 0.05) from saline (+0 min).
Chicks injected with 5 nmol/hem of serotonin showed good
retention levels at tests, except for the usual 15 min dip, until
30 min after training. Thereafter, the discrimination started to
decline, with amnesia fully developed by 60 min after training
(Figure 3B) and DRs 15, 60, 90, and 120 min being different from
those of saline injected (+0 min) chicks (P < 0.05).
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FIGURE 3 |The effect of serotonin on memory retention in chicks
given strongly reinforced training. (A) 5.0 nmol/hem serotonin
resulted in the inhibition of memory consolidation when injected
between −5 and +2.5 min relative to training, n = 16–19 per
group. (B) this dose of serotonin injected immediately after training
resulted in the gradual loss of memory after 30 min post training,
n = 15–20 per group, *P < 0.05 compared to saline-injected
animals.
EFFECT OF THE BROAD-SPECTRUM 5-HT RECEPTOR ANTAGONIST
METHIOTHEPIN
Dose-response function on strongly reinforced memory
When methiothepin, which inhibits ﬁve of the seven 5-HT recep-
tor families, including the 5-HT1 and 5-HT2 families, was injected
immediately after strongly reinforced training (Figure 4A) there
was an effect of drug concentration [F(5,77) = 4.67, P = 0.001].
However, only the 2.5 nmol/hem dose had a signiﬁcant inhibitory
effect (P = 0.002).
Time of administration and retention function on strongly reinforced
memory
Methiothepin impaired 120 min memory only when the inhibitor
was injected immediately or 2.5 min after training [F(7,112) = 4.57,
P < 0.001), although there still appeared to be some inhibi-
tion when it was injected 5 min before or 5 min after training
(Figure 4B). This is reminiscent of the inhibitory effect of high
concentration of serotonin (Figure 3A). As with the high dose
of serotonin, the methiothepin-induced memory deﬁcit was sig-
niﬁcantly different from saline at 40 min post-training and all
subsequent times [in contrast to most other statistical analy-
ses this result was reached by two-way ANOVA drug x times
F(7,238) = 3.48, P < 0.05; Figure 4C].
Weakly reinforced memory
Although the higher dose of methiothepin (10 nmol/hem) did
not inhibit strongly reinforced training (Figure 4A), it did con-
solidate weakly reinforced training (Figure 4D). 1.0 nmol/hem,
which also had no effect on strong training (Figure 4A) did, how-
ever, not affect weakly reinforced training (Figure 4D). This result
suggests that 10 nmol/hem rather than not having an effect on
memory retention, could be facilitating promotion of poor mem-
ory. Together these observations suggest (i) that methiothepin
acts on more than one 5-HT receptor involved in memory con-
solidation; (ii) that one of these two receptors promotes memory
and the other inhibits it; and (iii) that methiothepin has different
inhibitory potency on these receptors. For these reasons we turned
to the more speciﬁc 5-HT2B/C inhibitor SB221284.
EFFECT OF SELECTIVE 5-HT2B/C RECEPTOR ANTAGONIST, SB221284
Since a 10-fold higher concentration of serotonin was required
to inhibit strongly reinforced learning than was needed to con-
solidate weakly reinforced learning (Figure 1), we hypothesized
that the memory-enhancing effect of serotonin was exerted
on a methiothepin-inhibitable 5-HT receptor with high afﬁn-
ity for serotonin, i.e., the 5-HT2, the 5-HT6, or the 5-HT7
receptor (Misane and Ogren, 2000). This idea was supported
by the dose-response curve for the selective 5-HT2B/C recep-
tor antagonist SB221284, which abolished memory with 3 or
10 pmol/hem (Figure 5A; F(5,93) = 6.99, P < 0.001), whereas
0.3 or 1.0 pmol/hem had no effect.
Speciﬁcity of action of 5-HTon 5-HT2B/C receptors inmemory
enhancement was further demonstrated by challenging the 5-HT
enhancement of consolidation of weakly reinforced learning by
prior subcutaneous administration of 1 pmol/chick of SB221284.
This low dose produced a signiﬁcant shift in the dose-response
function for 5-HT, demonstrating the requirement of a higher
dose of 5-HT to enhance memory in the presence of SB221284
(Figure 5B). As in Figure 4C a two-way ANOVA was used to
reveal a drug effect [F(1,59) = 10.13, P = 0.002] and a signiﬁcant
dose effect [F(1,59) = 10.50, P = 0.002].
Time of administration and retention function for SB221284
SB221284 (10 pmol/hem) resulted in signiﬁcantmemory loss after
strongly reinforced training when injected immediately or 2.5 min
after training, and again when it was injected 25min after training.
[Figure 6A; F(7,114) = 9.07, p < 0.001]. Injection 5–20 min or
30 min after training did not affect memory processing.
When SB221284 (10 pmol/hem) was injected 2.5 min after
strongly reinforced training, memory was intact on test 10 and
30 min after training but signiﬁcantly reduced from 30 min on
[Figure 6B; F(5,85) = 11.60, P < 0.001].
EFFECT OF FLUOXETINE AND PAROXETINE
The 5-HT2B- and astrocyte-speciﬁc 5-HT receptor agonists ﬂu-
oxetine and paroxetine enhanced weakly reinforced training, with
similar time course to 5-HT,but did not inhibit strongly reinforced
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FIGURE 4 | Effect of the serotonin antagonist, methiothepin, on strongly
reinforced memory. (A) dose-response relationship for methiothepin
injected immediately after training, n = 11–17 per group. (B)Time of injection
of 2.5 nmol/hem of methiothepin relative to training and tested 120 min after
training, n = 11–19 per group. (C) Memory retention in different groups of
chicks tested at selected times after training and injection of methiothepin,
n = 13–18 per group. *P < 0.05. (D)Test of two contrasting doses of
methiothepin on memory following 20% anthranilate training, the low dose
does not promote consolidation, whereas the discrimination ratio after
administration of the high dose indicates normal memory retention,
n = 16–18 per group. * statistically signiﬁcant difference (P < 0.05) from
saline-injected animals.
FIGURE 5 | Effect of the selective 5-HT2B/C antagonist SB221284. (A)
Dose-response for SB221284 injected immediately after strongly reinforced
training into the IMM with chicks tested 120 min after training n = 16–19 per
group. (B) Challenge of 5-HT consolidation of weakly reinforced learning by
prior injection of a low subcutaneous dose of SB221284 15 min after and
administration of 5-HT into the IMM 20 min after training. The low dose of
SB221284, that by itself did not inhibit memory, resulted in the need for a
higher dose of 5-HT to enhance memory, P < 0.05, n = 15–16 per group.
* statistically different (P < 0.05) inA from saline and in B from similar results
in saline-injected animals.
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FIGURE 6 | Effect of the selective 5-HT2B/C receptor antagonist,
SB221284, on strongly reinforced memory. (A)Time of injection of
10 pmol/hem of SB221284 relative to training and tested 120 min after
training, n = 14–16 per group. (B) Memory retention tested at selected times
after training and injection of 10 pmol SB221284 per hem 2.5 min after
training, n = 14–16 per group, *P < 0.05 from saline-injected animals.
training like serotonin (see Figures 3A,B). Both ﬂuoxetine and
paroxetine promoted consolidation in a dose-dependent manner
(Figure 7A). The dose effects of both ﬂuoxetine [F(9,165) = 3.117,
P = 0.002] and paroxetine [F(5,92) = 8.882, P < 0.001] injected
immediately after training were signiﬁcant. As can be seen in
Figure 7A, 10 nmol/hem of ﬂuoxetine and paroxetine consolidate
weakly reinforced learning at least equally as well as 2.5 nmol sero-
tonin/hem, and there is at most a very small difference in potency
between the two SSRIs. As with serotonin, the window for sta-
tistically signiﬁcant memory consolidation by ﬂuoxetine stretches
from zero to 25 min after training [Figure 7B; F(6,119) = 7.75,
P < 0.001], with no effect at 30 and 40 min.
There was little inhibitory response found to ﬂuoxetine at a
high dose in sharp contrast to serotonin itself.
EFFECT OF INHIBITION OF GLYCOGENOLYSIS BY DAB IN
ENHANCEMENT BY 5-HT AND FLUOXETINE
5-HT promotes weakly reinforced training when administered
during both short-term and intermediate memory, i.e., admin-
istration 2.5 or 20 min after training (Figure 8A). A non-optimal
dose of DAB (10 pmol/chick) prevented 5-HT (1 nmol/hem)
from promoting weakly reinforced training during short-term
[F(2,47) = 6.20,P = 0.004] but notwhen givenduring intermediate
memory.
Similarly, DAB prevented ﬂuoxetine (7.5 nmol/hem) from pro-
moting weakly reinforced training during short-term memory
(ﬂuoxetine added at 2.5 min; F(2,49) = 6.80, P = 0.002), but
not during intermediate memory (ﬂuoxetine added at 20 min;
Figure 8B).
DISCUSSION
Serotonin exerts mnemonic actions on at least two different 5-
HT receptors during discriminated learning in day-old chick.
This is indicated by its production of a biphasic effect on mem-
ory with low doses facilitating weakly reinforced learning and
higher doses inhibiting strongly reinforced learning. The two
most important experimental observations in the present study
are: (i) that the memory-enhancing effect of serotonin on weakly
reinforced learning was at least as pronounced with any of the
speciﬁc 5-HT2B agonists ﬂuoxetine or paroxetine, and that these
FIGURE 7 | (A) Dose-response to ﬂuoxetine (1–50 nmol/hem) and paroxetine
(5.0–15 nmol/hem) administered into the IMM immediately after training on
weakly reinforced learning, n = 11–20 per group. (B)Time of injection function
after weakly reinforced training with injection of ﬂuoxetine (10 nmol/hem) into
the IMM at times from immediately after training to 40 min, n = 17–19 per
group, *P < 0.05 from saline-injected animals.
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FIGURE 8 | Ability of the inhibitor of glycogenolysis, DAB, to
prevent memory enhancement. (A) Enhancement of weakly
reinforced training by serotonin (1.0 nmol/hem, 2.5 min after training)
was prevented by the sub-optimal dose of DAB (10 pmol/hem) given
5 min before training but not when DAB was given 15 min after
training and serotonin 20 min after training. (B) Enhancement of
weakly reinforced training by ﬂuoxetine was only prevented by DAB
at the early period and not the later (intermediate) one at 20 min,
n = 12–20 per group, *P < 0.05 from animals injected with saline
at the same time.
two drugs were virtually equipotent; and (ii) that methiothepin
or SB221284 needed to be administered almost immediately after
strongly reinforced training to inhibit memory consolidation into
long-term memory. Nevertheless, the inhibitory effect did not
become manifest until after 30 min.
The ﬁrst observation positively identiﬁes the memory-
enhancing effect of serotonin as being 5-HT2B-mediated, which is
consistent with the effects of the inhibitory drugs. Although ﬂu-
oxetine is not generally known to be a subtype-speciﬁc 5-HT2B
receptor agonist, this effect has been clearly documented in pri-
mary cultures of mouse astrocytes (Li et al., 2008). Paroxetine
exerts similar and equipotent effects (Zhang et al.,2010). Qualitati-
tively and quantitatively identical effects were also found in intact
mouse brain and brain slices (Li et al., 2008), and action of ﬂu-
oxetine as a 5-HT2B receptor agonist was conﬁrmed in vivo (Diaz
et al., 2012). Furthermore, administration of ﬂuoxetine to mice
for 2 weeks followed by ﬂuorescence-activated cell sorting (FACS;
Lovatt et al., 2007; Cahoy et al., 2008) has shown an astrocyte-
speciﬁc increase in mRNA expression of the 5-HT2B receptor, but
of no other 5-HT2 receptors, as well as of the expression of several
non-serotonergic genes (Li et al., 2012; Hertz et al., in this Research
Project).
The effect of the glycogenolysis inhibitor, DAB, demonstrates
that serotonergic 5-HT2B receptor stimulation is the trigger of
the glycogenolysis occurring soon after one-trial aversive learning
in the day-old chick. As pointed out in Introduction, equipotent
stimulation of this subtype of the 5-HT2 receptor by any of the
conventional SSRIs stimulates a pathway leading to glycogenolysis
(Kong et al., 2002; Hertz et al., 2012). During learning in day-old
chicksDAB-mediated inhibition of the glycogenolytic period soon
after training abolishes memory (Gibbs et al., 2006a). A normally
occurring rise in IMMcontents of glutamate, glutamine and aspar-
tate in the left hemisphere simultaneous with the fall in glycogen
(Hertz et al., 2003) is also inhibited by DAB (Gibbs et al., 2007).
During the ﬁrst 30 min post-training, two periods of glutamate
release occur in the forebrain (Daisley et al., 1998). One period
occurs almost immediately after the aversive experience, when glu-
tamate release is conﬁned to the left hemisphere. A second release,
30 min later, appears to occur bilaterally (Daisley and Rose, 1994),
with preponderance of the right hemisphere, when glutamate level
is again increased (Hertz et al., 2003), although glycogen content
does not decrease. Increased pool sizes of glutamate probably
reﬂect increased astrocytic synthesis of glutamate and its transfer
via glutamine (a non-excitotoxic glutamate product and precur-
sor) to neurons, where it is converted back to glutamate and used
as transmitter glutamate (Hertz et al., 2003). Behavioral evidence
supports the idea that DAB administration exerts its amnestic
effect bypreventing glutamate supply, since the extinctionofmem-
ory following DAB administration 5 min before training can be
counteracted by injection of glutamine at the time of training.
Injection of lactate or the astrocyte-speciﬁc substrate acetate com-
bined with aspartate (compensating for the inability of acetate [in
contrast to lactate] to sustain the pyruvate carboxylation necessary
for glutamate formation) has a similar effect (Gibbs et al., 2008a).
These compounds rescue memory when injected either at training
or 10 min before the second glycogenolytic period, but they are
not effective later than 20 min after training (Gibbs et al., 2008a).
The effectiveness of acetate demonstrates that the effect is exerted
on astrocytes.
In addition to the inhibition in learning that occurs after
30 min when either methiothepin or the more selective 5-HT2B/C
inhibitor SB221284 is injected close to training, a dip in the
DR occurs after injection at 25 min (see Figure 6A) suggesting
that serotonin may also partly contribute to the second period
of sensitivity to DAB around 30 min, when no glycogenolysis
is apparent (O’Dowd et al., 1994; Gibbs et al., 2006b). How-
ever, more complete inhibition of memory (continuation beyond
30 min) by propranolol indicates that noradrenaline release
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and β2-adrenergic stimulation is the most important trigger of
glycogenolysis at this time. The serotonergic system, in con-
junction with the noradrenergic, dopaminergic and cholinergic
systems, operates as part of the diffuse modulatory system of the
central nervous system (e.g., Myhrer, 2003). All are implicated
in learning and memory. Serotonin is often involved in emo-
tionally tainted events, whereas the noradrenergic system shows a
less speciﬁc modus of activation, but due to its widespread pres-
ence interacts with many other transmitter systems, in this case
serotonin.
Simultaneous noradrenergic stimulation at α2- and β3-
adrenergic receptors may explain the lack of an obvious decrease
in glycogen content 30 min after training. This is because
α2-adrenergic receptor stimulation promotes glycogen synthesis
(Hertz et al., 2007; Hutchinson et al., 2011), which occurs simul-
taneously with glycogenolysis, as demonstrated by the memory
inhibition resulting from injection of an α2-adrenergic antagonist
up to 30 min post-training (Hertz and Gibbs, 2009). The impor-
tance of interaction between glycogenolysis and glycogen synthesis
has also been demonstrated by Gibbs and Hutchinson (2012).
Moreover, noradrenergic stimulation of β3-adrenergic receptors
stimulates glucose uptake up to 25 min after training (Gibbs and
Summers, 2000; Gibbs et al., 2008b). In contrast, activation of
serotonergic receptors does not stimulate glycogen synthesis or
glucose uptake in brain.
The lack of inhibition by the high dose of methiothepin could
be due to inhibition of autoreceptors, probably 5-HT1A receptors,
at this dose level, resulting in increased extracellular levels of sero-
tonin and the enhancement of memory consolidation. The result
in Figure 4D that 10 nmol/hem did consolidate weakly reinforced
training, observed after 120 min, whereas 1.0 nmol/hem had no
effect on weakly reinforced training is consistent with the concept
that the higher doses acting on autoreceptors, increased extra-
cellular 5-HT levels and therefore produce enhancement of weak
learning.
Other authors have also demonstrated the importance of
glycogenolysis in learning. Suzuki et al. (2011) showed that
memory and long-term potentiation (LTP) were abolished by
glycogenolytic inhibitor administration in rat hippocampus. New-
man et al. (2011) conﬁrmed memory impairment by inhibition
of intrahippocampal glycogenolysis. This impairment could be
counteracted by either lactate or glucose. Since blockade of the
neuronal monocarboxylate transporter impaired memory they
concluded that lactate might be a specially important substrate
for neurons during working memory, acting by rapidly pro-
viding additional energy. However, the ability of neurons to
metabolize glucose- or lactate-derived pyruvate may not have
been intact in the presence of the mononocarboxylate transport
inhibitor (Halestrap and Denton, 1975). Also, at least in cul-
tured neurons, lactate is not capable of supporting glutamatergic
activity (Bak et al., 2006, 2012), which is so essential for learn-
ing (Gibbs and Hertz, 2005). Neuronal lactate utilization cannot
be the mechanism operating during one-trial aversive learning
in day-old chicks, since the astrocyte-speciﬁc substrate acetate in
combination with aspartate (which does not provide a rapidly
metabolizeable substrate to neurons) rescued memory in these
animals after DAB administration. The importance of glycogen
for learning has been substantiated by Duran et al. (2013), who
demonstrated severe disturbances in long-term memory forma-
tion and learning-dependent synaptic plasticity in mice lacking
brain glycogen synthase.
In their introduction of the Suzuki et al. (2011) paper in “Neu-
ron,” Bezzi and Volterra (2011) suggested that aspects like the
trigger(s) and timing(s) of astrocytic glycogenolysis during learn-
ing need further investigation. We had previously shown that
glycogenolysis is essential for production of transmitter glutamate
during one-trial aversive learning in the day-old chick and occurs
during three periods during the ﬁrst hr after training (Gibbs et al.,
2008a). It has also long been known that noradrenaline triggers
the second period of glycogenolysis and we now present evidence
that the ﬁrst period is triggered by serotonin acting on 5-HT2B
receptors. The trigger for the third period remains unknown.
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